Category : Healthcare and Pharmaceuticals | Published at : July-2022 | Delivery Format : PDF | Status: Published | Pages : 160
The global controlled release drug delivery market size projected to register around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. The market is driven by increasing technology spending in healthcare sector.
Market Dynamics
Soaring demand for pediatric and geriatric controlled release delivery methods and substitute therapies and increasing consciousness about advantages of these systems over conventional forms are providing a fillip to the controlled release drug delivery market market.
These technologies deliver numerous advantages over old-style delivery forms. Uniform drug effect, reduced dosage and less gastrointestinal side effects, dosage frequency, enhanced patient compliance, improved drug efficacy & safety, and reduced fluctuation of plasma drug levels are some of the advantages delivered by these technologies.
Market Insights
Controlled release drug delivery systems permit reduction in quantity of dose and dose frequency, increased patient compliance and acceptance, less fluctuation in plasma drug levels, uniform drug result, and improved effectualness quantitative relation of administered therapeutic. as compared to traditional delivery, these systems accomplish a chronic therapeutic result, increase foregone conclusion in drug unleash dynamics, and produce concerning delivery at a pre-determined rate regionally or consistently. Thus, with many more blessings offered by these systems, their adoption is slated to extend at a motivating rate over the approaching years.
Market Segmentation
Market By Release Mechanism
- Polymer Based Systems
- Micro Reservoir Partition Controlled Drug Delivery Systems
- Feedback Regulated Drug Delivery Systems
- Activation-modulated Drug Delivery Systems
- Osmotic Pressure Activated
- Hydrodynamic Pressure Activated
- Vapor Pressure Activated
- Mechanically Activated
- Magnetically Activated
- Chemically Activated
- pH Activated
- Hydrolysis Activated
- Enzyme Activated
Market By Technology
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others
Market By Application
- Metered Dose Inhalers
- Injectable
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-drug delivery Systems
- Drug Eluting Stents
Market By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
Regional Insights
North America captures the largest revenue share at 35.6% and will continue to retain its dominance position over the forthcoming years. Speedy acceptance of advanced devices and technologies and high per capita healthcare expenditure are expected to surge the need for connected drug delivery systems in the region. High price of controlled release drug delivery is expected to be the one of the substantial factor in hampering the market growth in emerging regions such as MEA, APAC and Latin America. Though, with the growing numeral of market entrants the device prices are anticipated to fall over time; this will backing the market growth in emerging such countries such as India and China.
Market Participants
The major players associated with the controlled release drug delivery market Capsugel, Orbis Biosciences, Inc., Pfizer, Inc, Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Depomed, Inc., Corium International, Inc., and Aradigm Corporation. Most of these firms put stress on new product launch and mergers & acquisitions, technological expansion, and strategic partnership activities as part of their commercial growth strategies.
